VIGL: Vigil Neuroscience, Inc. Stock

by  •  • Comments Off on VIGL: Vigil Neuroscience, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 119.89
Enterprise Value ($M) 67.90
Book Value ($M) 116.25
Book Value / Share 3.09
Price / Book 1.03
NCAV ($M) 97.30
NCAV / Share 2.59
Price / NCAV 1.23

Profitability (mra)
Return on Invested Capital (ROIC) -0.64
Return on Assets (ROA) -0.43
Return on Equity (ROE) -0.48

Liquidity (mrq)
Quick Ratio 10.45
Current Ratio 10.45

Balance Sheet (mrq) ($M)
Current Assets 121.91
Assets 140.86
Liabilities 24.61
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -88.87
Net Income -82.64

Cash Flow Statement (mra) ($M)
Cash From Operations -70.36
Cash from Investing -65.14
Cash from Financing 0.89

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-29 13G/A Artal International S.C.A. 4.90 0.00
02-14 13G/A Deep Track Capital, LP 9.62 -0.95
02-14 13G/A Citadel Advisors Llc 6.00
02-12 13G/A Flynn James E 3.27 -42.81

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-08 59,146 526,670 11.23
2024-05-07 10,267 17,724 57.93
2024-05-06 14,175 18,359 77.21
2024-05-03 8,601 71,507 12.03

(click for more detail)

Similar Companies
UBX – Unity Biotechnology, Inc. UTHR – United Therapeutics Corporation
VERV – Verve Therapeutics, Inc. VIR – Vir Biotechnology, Inc.
VIRX – Viracta Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io